An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia | MicrobiomeTrials← Back to trialsNCT07634692
An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2026-07-17
Enrollment target: 250 participants Locations- Sanofi s.r.o., Prague, Czechia
Other microbiome trials you might be interested in
RSV Infection
This study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, an…
Birmingham, United StatesEst. completion Feb 24, 2028
Respiratory Syncytial Virus Infections+Metapneumovirus
The aim of this study is to evaluate the safety, reactogenicity, and immune response of the different formulations of th…
Botany, AustraliaEst. completion Apr 5, 2029